Resolution of osteonecrosis of the jaw after teriparatide (recombinant human PTH-(1-34)) therapy.

摘要

Although exceedingly rare in the population with postmenopausal osteoporosis, osteonecrosis of the jaw (ONJ) has a significant impact on the morbidity of the unfortunate patients who develop it. Currently recommended treatments have proven to be suboptimal, as many patients remain unresponsive.We describe the second case of teriparatide therapy for treatment of ONJ that was unresponsive to conventional therapies.